Skip to main content
Menu
US

HTRF Human Total SMAD3 Detection Kit, 10,000 Assay Points

The total SMAD3 kit detects cellular SMAD3 and can be used as a normalization assay with our phospho-SMAD3 kit to enable optimal investigation of TGF-ß signaling.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Feature Specification
Application Cell Signaling
Sample Volume 16 µL

The total SMAD3 kit detects cellular SMAD3 and can be used as a normalization assay with our phospho-SMAD3 kit to enable optimal investigation of TGF-ß signaling.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Unit Size: 500 Assay Points
Part #:
64ND3PEG
List Price
USD 2,147.00
Unit Size: 10,000 Assay Points
Part #:
64ND3PEH
List Price
USD 12,490.00

Overview

The total SMAD3 cellular assay kit is designed to monitor the expression level of SMAD3, whether phosphorylated or unphosphorylated. It is compatible with our Phospho-SMAD3 kit, and enables analysis of phosphorylated and total proteins from a single sample for better readout of TGF-ß signaling activity.

Specifications

Application
Cell Signaling
Brand
HTRF
Detection Modality
HTRF
Lysis Buffer Compatibility
Lysis Buffer 1
Lysis Buffer 3
Lysis Buffer 4
Lysis Buffer 5
Molecular Modification
Total
Product Group
Kit
Sample Volume
16 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Phosphoproteins
Target Species
Human
Technology
TR-FRET
Therapeutic Area
Cardiovascular
Metabolism/Diabetes
NASH/Fibrosis
Oncology & Inflammation
Unit Size
10,000 Assay Points

Video gallery

How it works

Total-SMAD3 assay principle

The Total-SMAD3 assay quantifies the expression level of SMAD3 in a cell lysate. Contrary to Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis or transfer. The Total-SMAD3 assay uses two labeled antibodies: one coupled to a donor fluorophore, the other to an acceptor. Both antibodies are highly specific for a distinct epitope on the protein. In presence of SMAD3 in a cell extract, the addition of these conjugates brings the donor fluorophore into close proximity with the acceptor and thereby generates a FRET signal. Its intensity is directly proportional to the concentration of the protein present in the sample, and provides a means of assessing the proteins expression under a no-wash assay format.

phospho-how-it-works-total-smad2-assay-principle

 

Total-SMAD3 2-plate assay protocol

The 2 plate protocol involves culturing cells in a 96-well plate before lysis then transferring lysates to a 384-well low volume detection plate before adding Total-SMAD3 HTRF detection reagents. This protocol enables the cells' viability and confluence to be monitored.

phospho-how-it-works-total-smad2-2-plate-assay-protocol

 

Total-SMAD3 1-plate assay protocol

Detection of total SMAD3 with HTRF reagents can be performed in a single plate used for culturing, stimulation and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.

phospho-how-it-works-total-smad2-1-plate-assay-protocol

 

Assay validation

Overactivation of TGF-ß/SMAD signaling in hepatocytes and HSCs promotes liver fibrosis

Human LX-2* and HepG2 lines were plated (50,000 and 200,000 cells/well respectively) and cultured overnight in complete culture medium, 37°C - 5% CO2. Cells were then treated with increasing concentrations of TGF-ß1 for 30 minutes at 37°C - 5% CO2. After medium removal, cells were lysed with 50 µL of supplemented lysis buffer #4 for 30 minutes at RT under gentle shaking, and 16 µL of lysate were transferred twice over into a low volume white microplate before adding 4 µL of the HTRF phospho-SMAD3 or total SMAD3 detection antibodies. The HTRF signal was recorded after an overnight incubation. In both lines, TGF-ß1 treatment induces SMAD3 phosphorylation on Ser423/425, while the expression level of the protein is not significantly affected.

*LX-2 cell line provided by EMD Millipore (Part #SCC064)

assay-validation-smad3-total-1

 

assay-validation-smad3-total-2

 

Validation on the mouse cell lines NIH/3T3 and C2C12

Mouse NIH/3T3 and C2C12 lines were plated (100,000 cells/well) and cultured 2H in complete culture medium, 37°C - 5% CO2. The day after, the cells were treated with increasing concentrations of TGF-ß1 for 30 minutes at 37°C - 5% CO2. After medium removal, the cells were lysed with 50 µL of supplemented lysis buffer #4 for 30 minutes at RT under gentle shaking, and 16 µL of lysate were transferred twice over into a low volume white microplate before adding 4 µL of the HTRF phospho-SMAD3 or total SMAD3 detection antibodies. The HTRF signal was recorded after an overnight incubation. In both lines, TGF-ß1 promotes the activation of SMAD3 by phosphorylation on Ser423/425, whereas the expression level of the protein remains fairly stable.

assay-validation-smad3-total-3

 

assay-validation-smad3-total-4

 

HTRF assay compared to Western Blot using total SMAD3 assay

Cells were cultured to 80% confluency and treated with TGF-ß1 for 30 minutes. Following lysis, soluble supernatants were collected via centrifugation. Serial dilutions of ysates were performed and transferred into a low volume white microplate before finally adding HTRF phospho-SMAD3 detection reagents. Equal amounts of lysates were used for a side by side comparison between HTRF and Western Blot. The results reveal that the HTRF phospho-SMAD3 assay is 16-fold more sensitive than the Western Blot.

assay-validation-smad3-total-5

 

Simplified pathway

TGF-ß signaling pathway

TGF-ß signaling is mediated by complexes of TßRI and TßRII which activate the intracellular SMAD3 by phosphorylation. The binding of the TGF-ß ligand on TßRII triggers the recruitment of TßRI into the ligand-receptor complex. TßRII autophosphorylates then transphosphorylates TßRI. Activated TßRI in turn phosphorylates SMAD3 on Ser423 and Ser425, enabling its oligomerization with SMAD4. This complex then translocates to the nucleus and acts as a transcription factor with coactivators and corepressors to regulate the expression of multiple genes involved in cell growth, apoptosis, proliferation, migration, and differentiation, as well as in extracellular matrix remodeling and immune/inflammatory responses. Inhibitory SMAD6 and SMAD7 are involved in feedback inhibition of the pathway.

phospho-pathway-tgf-beta-64nd3peg

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-2 of 2 Resources
Application Note Icon
Application Note
Download your application note on TGF-β SMAD α-SMA signaling in NASH

Discover the benefits of using HTRF assays to characterize liver fibrosis.

Several molecular markers have been investigated as...

Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Scroll Icon